Curcumin is a natural substance extracted from Curcuma longa Linn with beneficial pharmaceutical properties such as anticancer activity against several cellular lines. However, it presents poor bioavailability due to its low solubility in aqueous media and chemical instability. In this research, curcumin was encapsulated in polymer micelles obtained by the self-assembly of a biodegradable poly (ethylene glycol)-block-poly(ɛ-caprolactone) copolymer conjugated with cholesterol or oleic acid. A hydroxyl-terminated poly (ethylene glycol)-block-poly(ɛ-caprolactone) was reacted with cholesteryl chloroformate or oleyl chloride to obtain conjugated copolymers. The resulting polymeric materials were characterised through proton nuclear magnetic resonance, gel permeation chromatography and differential scanning calorimetry, and their critical aggregation concentration was measured through fluorescence spectroscopy. Poly (ethylene glycol)-block-poly(ɛ-caprolactone) conjugated with cholesterol and oleic acid posed an improved capacity of encapsulating curcumin, resulting in the loading capacities of 8.8% and 15.2%, respectively. Cell viability studies confirmed that curcumin loaded in polymer micelles maintained its anticancer activity against MCF-7 human breast cancer cells but presented low cytotoxicity against mouse fibroblasts. Hence, these formulations have good potential for applications in drug delivery systems for breast cancer treatment.
IresonCRJonesDJOrrS, et al. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Prevent Biomark2002; 11: 105–111.
2.
MaheshwariRKSinghAKGaddipatiJ, et al. Multiple biological activities of curcumin: a short review. Life Sci2006; 78: 2081–2087.
3.
AllegraAInnaoVRussoS, et al. Anticancer activity of curcumin and its analogues: preclinical and clinical studies. Cancer Invest2017; 35: 1–22.
4.
FarzaeiMZobeiriMParviziF, et al. Curcumin in liver diseases: a systematic review of the cellular mechanisms of oxidative stress and clinical perspective. Nutrients2018; 10: 855.
5.
Zorofchian MoghadamtousiSAbdul KadirHHassandarvishP, et al. A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int2014; 2014: 186864.
6.
MahalunkarSYadavASGorainM, et al. Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer. Int J Nanomed2019; 14: 8285.
7.
CarrollREBenyaRVTurgeonDK, et al. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prevent Res2011; 4: 354–364.
8.
SanidadKZSukamtohEXiaoH, et al. Curcumin: recent advances in the development of strategies to improve oral bioavailability. Ann Rev Food Sci Technol2019; 10: 597–617.
9.
AnandPKunnumakkaraABNewmanRA, et al. Bioavailability of curcumin: problems and promises. Mol Pharmaceut2007; 4: 807–818.
10.
DaiLLiRWeiY, et al. Fabrication of zein and rhamnolipid complex nanoparticles to enhance the stability and in vitro release of curcumin. Food Hydrocolloid2018; 77: 617–628.
11.
ShobaGJoyDJosephT, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica1998; 64: 353–356.
12.
ChangCMeikleTGSuY, et al. Encapsulation in egg white protein nanoparticles protects anti-oxidant activity of curcumin. Food Chem2019; 280: 65–72.
13.
AgelMRBaghdanEPinnapireddySR, et al. Curcumin loaded nanoparticles as efficient photoactive formulations against gram-positive and gram-negative bacteria. Colloid Surf B: Biointerf2019; 178: 460–468.
14.
WongKENgaiSCLeeL-H, et al. Curcumin nanoformulations for colorectal cancer: a review. Front Pharmacol2019; 10: 152.
15.
MahranRIHagrasMMSunD, et al. Bringing curcumin to the clinic in cancer prevention: a review of strategies to enhance bioavailability and efficacy. AAPS J2017; 19: 54–81.
16.
DiazILParraCLinarezM, et al. Design of micelle nanocontainers based on PDMAEMA-b-PCL-b-PDMAEMA triblock copolymers for the encapsulation of amphotericin B. AAPS Pharmscit2015; 16: 1069–1078.
17.
WangZDengXDingJ, et al. Mechanisms of drug release in pH-sensitive micelles for tumour targeted drug delivery system: a review. Int J Pharmaceut2018; 535: 253–260.
18.
KataokaKHaradaANagasakiY.Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev2012; 64: 37–48.
19.
GongJChenMZhengY, et al. Polymeric micelles drug delivery system in oncology. J Control Rel2012; 159: 312–323.
20.
El-NaggarMEAl-JoufiFAnwarM, et al. Curcumin-loaded PLA-PEG copolymer nanoparticles for treatment of liver inflammation in streptozotocin-induced diabetic rats. Colloid Surf B: Biointerf2019; 177: 389–398.
21.
LiJLeeIWShinGH, et al. Curcumin-Eudragit® E PO solid dispersion: a simple and potent method to solve the problems of curcumin. Europ J Pharmaceut Biopharmaceut2015; 94: 322–332.
22.
SahuABoraUKasojuN, et al. Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)–palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomater2008; 4: 1752–1761.
23.
LiHYZhangBChanPS, et al. Convergent synthesis and characterization of fatty acid-conjugated poly(ethylene glycol)-block-poly(epsilon-caprolactone) nanoparticles for improved drug delivery to the brain. Europ Polym J2018; 98: 394–401.
24.
YangRZhangSKongD, et al. Biodegradable polymer-curcumin conjugate micelles enhance the loading and delivery of low-potency curcumin. Pharmaceut Res2012; 29: 3512–3525.
25.
MeierMAAertsSNStaalBB, et al. PEO-b-PCL block copolymers: synthesis, detailed characterization, and selected micellar drug encapsulation behavior. Macromol Rapid Commun2005; 26: 1918–1924.
26.
DengHLiuJZhaoX, et al. PEG-b-PCL copolymer micelles with the ability of pH-controlled negative-to-positive charge reversal for intracellular delivery of doxorubicin. Biomacromolecules2014; 15: 4281–4292.
DengHDongASongJ, et al. Injectable thermosensitive hydrogel systems based on functional PEG/PCL block polymer for local drug delivery. J Control Releas2019; 297: 60–70.
29.
BrandtJVPiazzaRDdos SantosCC, et al. Synthesis and colloidal characterization of folic acid-modified PEG-b-PCL Micelles for methotrexate delivery. Colloid Surf B: Biointerf2019; 177: 228–234.
30.
ParkCYooJLeeD, et al. Chlorin e6-Loaded PEG-PCL nanoemulsion for photodynamic therapy and in vivo drug delivery. Int J Mol Sci2019; 20: 3958.
31.
SongYTianQHuangZ, et al. Self-assembled micelles of novel amphiphilic copolymer cholesterol-coupled F68 containing cabazitaxel as a drug delivery system. Int J Nanomed2014; 9: 2307.
32.
QuinteroCVeraRPerezLD.α-Tocopherol loaded thermosensitive polymer nanoparticles: preparation, in vitro release and antioxidant properties. Polímeros2016; 26: 304–312.
33.
Basu RayGChakrabortyIMoulikSP. Pyrene absorption can be a convenient method for probing critical micellar concentration (CMC) and indexing micellar polarity. J Colloid Interf Sci2006; 294: 248–254.
34.
Dechy-CabaretOMartin-VacaBBourissouD.Controlled ring-opening polymerization of lactide and glycolide. Chem Rev2004; 104: 6147–6176.
35.
HajipourAMazloumiG. An efficient and simple procedure for preparation of esters and anhydrides from acid chlorides in the presence of 1, 4-diazabicyclo [2.2. 2] Octane (DABCO) under solvent-free conditions. Synthetic Commun2002; 32: 23–30.
36.
BogdanovBVidtsAVan Den BuickeA, et al. Synthesis and thermal properties of poly(ethylene glycol)-poly(ɛ-caprolactone) co-polymers. Polymer1998; 39: 1631–1636.
37.
HuangYLiLLiG.An enzyme-catalysed access to amphiphilic triblock copolymer of PCL-b-PEG-b-PCL: synthesis, characterization and self-assembly properties. Design Monomer Polym2015; 18: 799–806.
38.
VerheyenSAugustijnsPKingetR, et al. Melting behavior of pure polyethylene glycol 6000 and polyethylene glycol 6000 in solid dispersions containing diazepam or temazepam: a DSC study. Thermochim Acta2001; 380: 153–164.
39.
SamantaSRoccatanoD.Interaction of curcumin with PEO–PPO–PEO block copolymers: a molecular dynamics study. J Phys Chem B2013; 117: 3250–3257.
40.
KondoTSawatariCManleyRSJ, et al. Characterization of hydrogen bonding in cellulose-synthetic polymer blend systems with regioselectively substituted methylcellulose. Macromolecules1994; 27: 210–215.
41.
ZhangYXiaoXZhouJJ, et al. Re-assembly behaviors of polystyrene-b-poly(acrylic acid) micelles. Polymer2009; 50: 6166–6171.
42.
AhmadZShahASiddiqM, et al. Polymeric micelles as drug delivery vehicles. RSC Adv2014; 4: 17028–17038.
43.
MirzaeiHMasoudifarASahebkarA, et al. MicroRNA: a novel target of curcumin in cancer therapy. J Cell Physiol2018; 233: 3004–3015.
44.
KurzrockRLiLMehtaK, et al. Liposomal curcumin for treatment of cancer. US20190105287, 2019.
45.
RaufAImranMOrhanIE, et al. Health perspectives of a bioactive compound curcumin: a review. Trend Food Sci Tech2018; 74: 33–45.
46.
HewlingsSKalmanD.Curcumin: a review of its’ effects on human health. Foods2017; 6: 92.
47.
PerroneDArditoFGiannatempoG, et al. Biological and therapeutic activities, and anticancer properties of curcumin. Experim Therapeutic Med2015; 10: 1615–1623.
48.
SongXZhangMDaiE, et al. Molecular targets of curcumin in breast cancer. Mol Med Report2019; 19: 23–29.
49.
DuanDWangANiL, et al. Trastuzumab- and Fab’ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo. Int J Nanomed2018; 13: 1831–1840.
50.
Tabatabaei MirakabadFSAkbarzadehAMilaniM, et al. A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line. Artif Cell Nanomed Biotech2016; 44: 423–430.
51.
DoktorovovaSSoutoEBSilvaAM.Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines. Pharmaceut Develop Technol2018; 23: 96–105.
52.
HuCLiMGuoT, et al. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT. Phytomedicine2019; 58: 152740.
53.
GhaffariS-BSarrafzadehM-HFakhroueianZ, et al. Flower-like curcumin-loaded folic acid-conjugated ZnO-MPA- βcyclodextrin nanostructures enhanced anticancer activity and cellular uptake of curcumin in breast cancer cells. Mater Sci Eng: C2019; 103: 109827.
54.
KunihiroAGBrickeyJAFryeJB, et al. Curcumin, but not curcumin-glucuronide, inhibits Smad signaling in TGFβ-dependent bone metastatic breast cancer cells and is enriched in bone compared to other tissues. J Nutritional Biochem2019; 63: 150–156.
55.
Esfandiarpour-BoroujeniSBagheri-KhoulenjaniSMirzadehH, et al. Fabrication and study of curcumin loaded nanoparticles based on folate-chitosan for breast cancer therapy application. Carbohydrate Polym2017; 168: 14–21.
56.
ZhangJChenXGHuangL, et al. Self-assembled polymeric nanoparticles based on oleic acid-grafted chitosan oligosaccharide: biocompatibility, protein adsorption and cellular uptake. J Mater Sci: Mater Med2012; 23: 1775–1783.
57.
RichieriGVAnelAKleinfeldAM.Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB. Biochemistry1993; 32: 7574–7580.
58.
PozziDColapicchioniVCaraccioloG, et al. Effect of polyethyleneglycol (PEG) chain length on the bio–nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. Nanoscale2014; 6: 2782–2792.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
